| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |